Ajaz, F.; Haddad, J.; Huda, B.; Yousuf, M.; Patnaik, R.; Bhurka, F.; Banerjee, Y.
Epigallocatechin Gallate as a Molecular Therapeutic in Heart Failure and Cardio-Oncology: Mechanistic Pathways and Translational Perspectives. Int. J. Mol. Sci. 2025, 26, 10798.
https://doi.org/10.3390/ijms262110798
AMA Style
Ajaz F, Haddad J, Huda B, Yousuf M, Patnaik R, Bhurka F, Banerjee Y.
Epigallocatechin Gallate as a Molecular Therapeutic in Heart Failure and Cardio-Oncology: Mechanistic Pathways and Translational Perspectives. International Journal of Molecular Sciences. 2025; 26(21):10798.
https://doi.org/10.3390/ijms262110798
Chicago/Turabian Style
Ajaz, Faika, Jewel Haddad, Bintul Huda, Maryam Yousuf, Rajashree Patnaik, Farida Bhurka, and Yajnavalka Banerjee.
2025. "Epigallocatechin Gallate as a Molecular Therapeutic in Heart Failure and Cardio-Oncology: Mechanistic Pathways and Translational Perspectives" International Journal of Molecular Sciences 26, no. 21: 10798.
https://doi.org/10.3390/ijms262110798
APA Style
Ajaz, F., Haddad, J., Huda, B., Yousuf, M., Patnaik, R., Bhurka, F., & Banerjee, Y.
(2025). Epigallocatechin Gallate as a Molecular Therapeutic in Heart Failure and Cardio-Oncology: Mechanistic Pathways and Translational Perspectives. International Journal of Molecular Sciences, 26(21), 10798.
https://doi.org/10.3390/ijms262110798